The new “dual strategy” enables production of CEPT® systems both in Asia and Europe. The critical treatment chamber for solid foods can also be produced in North America. Establishing new production lines on several continents allows for increased manufacturing speed and stability. OptiCept now has the capacity to build up to 500 CEPT® systems annually.

“We have worked intensively to establish these production lines to secure deliveries to our key markets. The increased production capacity also means that we are ready for upcoming order inflows. We are now well positioned to capitalize on demand in the food industry,” explains Thomas Lundqvist, CEO of OptiCept.

In addition to increased capacity, the strategy provides stability in material supply and production, as well as geopolitical advantages such as reduced risk from trade tariffs. The strategy also provides access to more components and greater flexibility in supplier choice, leading to significant cost benefits.

“With production on several continents, we reduce our vulnerability and gain a stronger negotiating position as we can leverage different production systems against each other. The reduced costs that follow open up new markets and strengthen our competitiveness in both liquid and solid foods,” continues Thomas Lundqvist, CEO of OptiCept.

The dual strategy is a step toward OptiCept’s goal of becoming the world’s leading supplier of PEF technology in the food industry.